Acurx pharmaceuticals to present at the microcap conference, january 28, 2025 - january 30, 2025

Staten island, ny / accesswire / december 11, 2024 / acurx pharmaceuticals, inc. ("acurx" or the "company") (nasdaq:acxp), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that david p. luci, president & chief executive officer, will be presenting at the microcap conference, which will take place january 28 to january 30, 2025 at the borgata hotel, atlantic city, new jersey.
ACXP Ratings Summary
ACXP Quant Ranking